Sedivention
Sedivention is a MedTech company, headquartered in Germany.
Entry
2026
Hold
0yr
Status
Active
Est. EV
–
Who owns Sedivention?
Sedivention is currently owned by bmp Ventures AG through IBG Risikokapitalfonds IV (2023 vintage), since 2026.
Hand-verified · updated 2026-07-03
More from IBG Risikokapitalfonds IV
Other portfolio companies in the same fund.
More PE-backed in MedTech
Comparable medtech deals from other GPs.
Data refreshed weekly · Sourced from public filings